Biodesix (BDSX)
Uses multi-omic testing to address clinical questions in lung disease.
$28.60
vs last close+0.45 (+1.60%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
−$0.74
Revenue estimate
$27.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.20−$1.60−$1.60−$1.16−$0.49−$0.81−$0.71Pending
Estimate−$0.07−$1.40−$1.40−$1.60−$1.05−$1.26−$0.90−$0.74
Surprise−1,614.3%−14.6%−14.3%+27.5%+53.3%+35.7%+21.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$20.4M$18.0M$20.0M$21.8M$28.8M$25.6M$26.9MPending
Estimate$19.9M$19.4M$18.6M$21.0M$25.7M$23.1M$26.0M$27.6M
Surprise+2.8%−7.5%+7.8%+3.8%+11.8%+10.5%+3.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.19 | — | — |
| Sep 2027 | −$0.42 | — | — |
| Jun 2027 | −$0.54 | — | — |
| Mar 2027 | −$0.64 | — | — |
| Dec 2026 | −$0.43 | — | — |
| Nov 2026 | −$0.74 | — | — |
| Aug 2026 | −$0.90 | −$0.71 | +21.3% |
| May 2026 | −$1.26 | −$0.81 | +35.7% |
| Feb 2026 | −$1.05 | −$0.49 | +53.3% |
| Nov 2025 | −$1.60 | −$1.16 | +27.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.19 | — | — | $37.2M | — | — | — |
| Sep 2027 | −$0.42 | — | — | $33.6M | — | — | — |
| Jun 2027 | −$0.54 | — | — | $32.2M | — | — | — |
| Mar 2027 | −$0.64 | — | — | $30.1M | — | — | — |
| Dec 2026 | −$0.43 | — | — | $32.0M | — | — | — |
| Nov 2, 2026 | −$0.74 | — | — | $27.6M | — | — | — |
| Aug 5, 2026 | −$0.90 | −$0.71 | +21.3% | $26.0M | $26.9M | +3.2% | −3.0% |
| May 4, 2026 | −$1.26 | −$0.81 | +35.7% | $23.1M | $25.6M | +10.5% | +32.6% |
| Feb 26, 2026 | −$1.05 | −$0.49 | +53.3% | $25.7M | $28.8M | +11.8% | +7.8% |
| Nov 3, 2025 | −$1.60 | −$1.16 | +27.5% | $21.0M | $21.8M | +3.8% | +19.9% |
| Aug 7, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 1, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 1, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Dec 10, 2020 | |||||||
| Oct 29, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |